Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
about
Graft-versus-host disease: why have we not made more progress?Acute graft-versus-host disease: a bench-to-bedside update.Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statementPrognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.Recent advances in the management of graft-versus-host disease.Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure.Reduced mortality after allogeneic hematopoietic-cell transplantation.Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre studyDecreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantationIntensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipientsEvaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantationManagement of acute graft-versus-host disease in children.Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.Mesenchymal stromal cells: a new tool against graft-versus-host disease?Plasma biomarkers of lower gastrointestinal and liver acute GVHD.Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells.First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.Have we improved in preventing and treating acute graft-versus-host disease?Discovery and validation of graft-versus-host disease biomarkersPreclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?Advances in the treatment of acute graft-versus-host disease.Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials NetworkTreatment and management of graft-versus-host disease: improving response and survival.Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.Acute graft-versus-host disease: new treatment strategies.A novel soluble form of Tim-3 associated with severe graft-versus-host disease.Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challengeAssessing response of therapy for acute and chronic graft-versus-host disease.Thinking out of the box--new approaches to controlling GVHD.Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.State-of-the-art acute and chronic GVHD treatment.Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.Sirolimus for treatment of steroid-refractory acute graft-versus-host disease.Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
P2860
Q27012940-949A1A34-189B-4401-8B5B-374269E5AF5DQ27687130-7385B377-40E2-442E-A6A1-F51B01F11885Q33622648-4A3AB289-A9F6-40F7-BFE9-A75D18B639C9Q33838584-09EE0F8A-4366-461C-A36E-C4A75C4CBDC7Q34428890-E75B5DDC-633E-40BD-970B-D1F8EAB4ED9CQ34463636-7543AC15-C0B8-4D5E-9310-9443CDD00509Q34472861-DA358F18-676F-4FC0-B04B-B479C28289D4Q34707280-C9BD1DEB-8582-41DF-B3AE-D3CD5306E3EDQ35042830-E285B85D-C055-483F-999D-8A3D9B60E17AQ35120338-29E7C4B1-7355-402D-B095-8A7C8870F97CQ35465005-2A065F28-96DA-49E5-B38A-3604636BBAA5Q35553386-7C3C1E26-F350-48B2-AECC-96E27E2F9DDAQ35574785-F71C8693-6B29-48E6-ABC9-1EAA2EE04C18Q35583009-D6DAB984-0F89-4391-95CF-3F1B19BD1F85Q35669901-49B33061-F7F7-44CB-9F9E-7472D884B3CCQ35820356-D7E62A3E-0E17-4D89-BA23-66A7A6C8E33BQ35848391-7597801A-5031-4329-AA21-49523A7AFD52Q35891657-58AD8E16-76E6-497D-B900-30AA794D6BBEQ35975038-6CBF5C06-7B1C-4022-BC07-AEC682FACE5FQ36113205-9C61B412-10C1-45E5-B237-41AD3FCA3B22Q36203692-137E38B5-B433-4E84-93E3-0642DF201792Q36569667-C5BCED77-9844-4B0C-852E-B0ED3C24F3CDQ37035815-5DA3189E-ACF9-4FD8-8F57-0491455D4D25Q37191057-CB02C434-ADA7-4849-9B5F-FA205FCA28A4Q37268948-6E66ECEE-21C8-4A2A-835C-BA3490D0E4D2Q37371836-0B03AE90-B947-4078-B936-36D49F5C9356Q37552088-22EBEEA4-32E9-46BF-8086-CD21DE6E130DQ37610714-2CEC66CA-5308-44E3-8B1A-D19334396EB2Q37665262-A2744E1D-41A1-4162-A20B-1983C0FF9562Q38066877-C6766303-39FC-46AC-ACC6-B7E33FB3AEBDQ38078431-4FD6FCC4-6AB4-4332-859A-DB196A206E0DQ38175862-974C4265-E54F-4328-BEE0-8EF682F52736Q38416371-97813B17-5891-4168-B72C-C7F70AFF04DDQ38416376-5CB5181B-04E4-42B2-9F8C-C16B2C3D982AQ39041077-80B0EAD2-5E20-4351-8178-854EA851DAF7Q39042251-D6F474DF-C49E-4C5A-A050-649BA9E552B0Q39401817-ABC4F7D7-C202-401E-8E7C-CC8A1D1AEB89Q41290373-9CAD0A8D-6C0C-4583-BAA5-7D8986BF1ED4Q43228479-23F84CC5-A6B7-4582-B612-CF29A22B7C07Q48208819-98E04C8B-6352-4C9E-8423-BFC9373E463F
P2860
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Initial therapy of acute graft ...... t compromise patient outcomes.
@en
Initial therapy of acute graft ...... t compromise patient outcomes.
@nl
type
label
Initial therapy of acute graft ...... t compromise patient outcomes.
@en
Initial therapy of acute graft ...... t compromise patient outcomes.
@nl
prefLabel
Initial therapy of acute graft ...... t compromise patient outcomes.
@en
Initial therapy of acute graft ...... t compromise patient outcomes.
@nl
P2093
P2860
P50
P1433
P1476
Initial therapy of acute graft ...... t compromise patient outcomes.
@en
P2093
George B McDonald
Kieren A Marr
Kristine Doney
Mary E D Flowers
Paul A Carpenter
Paul J Martin
Richard A Nash
Stephanie Lee
Terry Furlong
P2860
P304
P356
10.1182/BLOOD-2008-07-168401
P407
P50
P577
2008-11-10T00:00:00Z